Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.0.2 replaces v3.0.1, and the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:42:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:59:02.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has added a facility name and location related to Hemic and Lymphatic Diseases, specifically mentioning Lymphoma, Follicular, and pembrolizumab, while removing various related terms and resources.
    Difference
    4%
    Check dated 2025-08-31T12:19:08.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-24T08:13:30.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:48:26.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.5%
    Check dated 2025-08-10T00:40:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.